DS

Damien Soghoian

Venture Partner at Foresite Labs

San Francisco Bay Area

Overview

Work Experience

FL

Foresite Labs

  • Venture Partner

    2024 - Current

GH

Global Health Investment Corporation

  • Health Security Advisor

    2023

  • Managing Director

    2022 - 2023

FC

Foresite Capital

  • Director

    2018 - 2022

FL

Foresite Labs

  • Head of Strategy and Operations

    2018 - 2022

TC

The Council on Strategic Risks

  • Fellow, Ending Bioweapons Programs

    2020 - 2021

VL

Verily Life Sciences

  • Science Lead, Project Baseline Study

    2017 - 2018

    Project Baseline is a broad effort designed to develop a well-defined reference, or "baseline," of good health as well as a rich data platform that may be used to better understand the transition from health to disease and identify additional risk factors for disease.

  • Senior Scientist, Immunology Technical Lead, Immunoscape Platform

    2014 - 2018

    Verily is pursuing research in systems biology, nanotechnology, and biomedical systems engineering, with potential applications for immuno-oncology and other areas. We combine experimental capabilities with computational biology to support data generation and analysis across our clinical programs.

G

Google

  • Scientist

    2014 - 2016

    Google[x], Google Life Sciences

RI

Ragon Institute of MGH, MIT, and Harvard

  • Graduate Student

    2010 - 2014

    PI: Bruce Walker - Human immune profiling - CD4 and CD8 immunology - Anti-viral and vaccine immune responses - CyTOF (mass cytometry) and other high-dimensional technologies

HU

Harvard University

  • Graduate Student

    2009 - 2014

California Institute of Technology

  • Researcher

    2004 - 2007

    PI: Pamela Bjorkman

Education

Relevant Websites